This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Bergen Teknologioverføring, The Administrators of the Tulane Educational Fund, Vestlandets Innovasjonsselskap as (Vis). Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 249 
1 out of 1 Years Active: 2019-2026
Title: Pål Puntervoll: Innovator in Vaccine Development
Introduction
Pål Puntervoll is a notable inventor based in Bergen, Norway. He has made significant contributions to the field of vaccine development, particularly through his innovative patent.
Latest Patents
Pål Puntervoll holds a patent for a vaccine that features a mutant of an heat-stable toxin (ST). The wild-type sequence of this toxin is NSSNYCCELCCNPACTGCY, and the mutant includes mutations selected from the group consisting of A14H, A14T, and N12T. This patent represents a crucial advancement in vaccine technology.
Career Highlights
Throughout his career, Pål has worked with various organizations, including Bergen Teknologioverføring and The Administrators of the Tulane Educational Fund. His work has been instrumental in advancing research and development in the field of biotechnology.
Collaborations
Pål has collaborated with esteemed colleagues such as Halvor Sommerfelt and John D. Clements. These partnerships have further enriched his contributions to the scientific community.
Conclusion
Pål Puntervoll's innovative work in vaccine development showcases his dedication to advancing medical science. His patent and collaborations highlight his significant role in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile